In vivo efficacy of GFRA1-ADC. (A) Subcutaneous ACHN sorted by
relevance

Admin14.09.2021

In vivo efficacy of GFRA1-ADC. (A) Subcutaneous ACHN

4101
Admin27.07.2021

In vivo efficacy of GFRA1-ADC. (A) Subcutaneous ACHN

9508
Admin18.08.2021

In vivo efficacy of GFRA1-ADC. (A) Subcutaneous ACHN

Admin01.08.2021

In vivo efficacy of GFRA1-ADC. (A) Subcutaneous ACHN

5703
Admin30.09.2021

In vivo efficacy of GFRA1-ADC. (A) Subcutaneous ACHN

8000
Admin15.08.2021

In Vivo efficacy of combined Src and STAT3 inhibition. A

2809
Admin27.08.2021

MLN0128 has in vivo antitumor efficacy. Mice bearing ZR75

4004
Admin05.10.2021

SFN potentiated cisplatin-mediated efficacy in vivo. A

9501
Admin22.08.2021

MLN0128 has in vivo antitumor efficacy. Mice bearing ZR75

Admin09.10.2021

TWEAK induces proliferation, survival, and immune

205
Admin17.09.2021

An ErbB3 Antibody, MM-121, Is Active in Cancers with

9802
Admin01.09.2021

GA201 (RG7160): A Novel, Humanized, Glycoengineered Anti

3501
Admin18.08.2021

Oncotarget | Epithelial to mesenchymal transition is

8509
Admin10.10.2021

MLN0128 has in vivo antitumor efficacy. Mice bearing ZR75

509
Admin07.08.2021

Human Renal Cell Carcinoma Cell Lines Sn12c | ATCC | Bioz

5900
Admin20.07.2021

Nci N87 | ATCC | Bioz

3806
Admin06.10.2021

GV1001 Induces Apoptosis by Reducing Angiogenesis in Renal

1700
Admin01.09.2021

Romidepsin

Admin30.07.2021

Novel Cancer Therapeutics with Allosteric Modulation of

1505
Admin02.08.2021

(PDF) RG7212 Anti-TWEAK mAb Inhibits Tumor Growth through

4104
Admin17.08.2021

Apigenin inhibits tumorigenicity in ACHN cell xenograft

1606